Literature DB >> 21084706

Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development.

Marlene S Williams1, Ethan J Weiss, Marc S Sabatine, Daniel I Simon, Wadie F Bahou, Lewis C Becker, Leslie V Parise, Harold L Dauerman, Patricia A French, Susan S Smyth, Richard C Becker.   

Abstract

Understanding genetic contributions to platelet function could have profound clinical ramifications for personalizing platelet-directed pharmacotherapy, by providing insight into the risks and possible benefits associated with specific genotypes. This article represents an integrated summary of presentations related to genetic regulation of platelet receptor expression and function given at the Fifth Annual Platelet Colloquium in January 2010. It is supplemented with additional highlights from the literature covering (1) approaches to determining and evidence for the associations of genetic variants with platelet hypo- and hyperresponsive phenotypes, (2) the ramifications of these polymorphisms with regard to clinical responses to antiplatelet therapies, and (3) the role of platelet function/genetic testing in guiding antiplatelet therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084706      PMCID: PMC4118751          DOI: 10.1161/ATVBAHA.110.218131

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  135 in total

1.  Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke.

Authors:  L E Carlsson; A Greinacher; C Spitzer; R Walther; C Kessler
Journal:  Stroke       Date:  1997-07       Impact factor: 7.914

2.  Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes.

Authors:  J P McRedmond; S D Park; D F Reilly; J A Coppinger; P B Maguire; D C Shields; D J Fitzgerald
Journal:  Mol Cell Proteomics       Date:  2003-11-25       Impact factor: 5.911

3.  Polymorphisms of platelet glycoproteins in relation to macrovascular disease in type 2 diabetes mellitus.

Authors:  A M Carter; M W Mansfield; P J Grant
Journal:  Diabet Med       Date:  1998-04       Impact factor: 4.359

4.  Polymorphism of the platelet glycoprotein IIIa gene in patients with coronary stenosis.

Authors:  M Garcia-Ribes; D Gonzalez-Lamuño; R Hernandez-Estefania; T Colman; M Pocovi; M Delgado-Rodriguez; M Garcia-Fuentes; J M Revuelta
Journal:  Thromb Haemost       Date:  1998-06       Impact factor: 5.249

5.  Integrin binding and mechanical tension induce movement of mRNA and ribosomes to focal adhesions.

Authors:  M E Chicurel; R H Singer; C J Meyer; D E Ingber
Journal:  Nature       Date:  1998-04-16       Impact factor: 49.962

6.  Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets.

Authors:  A S Weyrich; D A Dixon; R Pabla; M R Elstad; T M McIntyre; S M Prescott; G A Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

7.  Hereditary variation in platelet integrin alpha 2 beta 1 density is associated with two silent polymorphisms in the alpha 2 gene coding sequence.

Authors:  T J Kunicki; M Kritzik; D S Annis; D J Nugent
Journal:  Blood       Date:  1997-03-15       Impact factor: 22.113

8.  Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: the Stroke Prevention in Young Women Study.

Authors:  K R Wagner; W H Giles; C J Johnson; C Y Ou; P F Bray; P J Goldschmidt-Clermont; J B Croft; V K Brown; B J Stern; B R Feeser; D W Buchholz; C J Earley; R F Macko; R J McCarter; M A Sloan; P D Stolley; R J Wityk; M A Wozniak; T R Price; S J Kittner
Journal:  Stroke       Date:  1998-03       Impact factor: 7.914

9.  Correlation between the polymorphism of glycoprotein Ia gene and acute coronary syndrome.

Authors:  Yonghui Zhao; Yanni Wang; Jiaqing Zhu
Journal:  Chin Med Sci J       Date:  2004-03

10.  [Genetic risk factors for ischemic cerebrovascular disease--analysis on fifteen candidate prothrombotic gene polymorphisms in the Japanese population].

Authors:  Keiko Ishii; Mitsuru Murata; Shuji Oguchi; Eiko Takeshita; Daisuke Ito; Norio Tanahashi; Yasuo Fukuuchi; Ikuo Saitou; Yasuo Ikeda; Kiyoaki Watanabe
Journal:  Rinsho Byori       Date:  2004-01
View more
  4 in total

1.  Time-dependent changes in non-COX-1-dependent platelet function with daily aspirin therapy.

Authors:  Deepak Voora; Thomas L Ortel; Joseph E Lucas; Jen-Tsan Chi; Richard C Becker; Geoffrey S Ginsburg
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

Review 2.  The pharmacogenetics of antiplatelet agents: towards personalized therapy?

Authors:  Tariq Ahmad; Deepak Voora; Richard C Becker
Journal:  Nat Rev Cardiol       Date:  2011-08-09       Impact factor: 32.419

Review 3.  The genetics of common variation affecting platelet development, function and pharmaceutical targeting.

Authors:  A D Johnson
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

4.  Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis.

Authors:  Kakali Ghoshal; Maitree Bhattacharyya
Journal:  ScientificWorldJournal       Date:  2014-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.